The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
Abstract
BACKGROUND: N-Acetylcysteine, theophylline, and other agents have shown inconsistent results in reducing contrast-induced nephropathy. PURPOSE: To determine the effect of these agents on preventing nephropathy. DATA SOURCES: Relevant randomized, controlled trials were identified by computerized searches in MEDLINE (from 1966 through 3 November 2006), EMBASE (1980 through November 2006), PubMed, Web of Knowledge (Current Contents Connect, Web of Science, BIOSIS Previews, and ISI Proceedings for the latest 5 years), and the Cochrane Library databases (up to November 2006). Databases were searched for studies in English, Spanish, French, Italian, and German. STUDY SELECTION: Randomized, controlled trials that administered N-acetylcysteine, theophylline, fenoldopam, dopamine, iloprost, statin, furosemide, or mannitol to a treatment group; used intravenous iodinated contrast; defined contrast-induced nephropathy explicitly; and reported sufficient data to construct a 2 x 2 table of the primary effect measure. DATA EXTRACTION: Abstracted information included patient characteristics, type of contrast media and dose, periprocedural hydration, definition of contrast-induced nephropathy, and prophylactic agent dose and route. DATA SYNTHESIS: In the 41 studies included, N-acetylcysteine (relative risk, 0.62 [95% CI, 0.44 to 0.88]) and theophylline (relative risk, 0.49 [CI, 0.23 to 1.06]) reduced the risk for contrast-induced nephropathy more than saline alone, whereas furosemide increased it (relative risk, 3.27 [CI, 1.48 to 7.26]). The remaining agents did not significantly affect risk. Significant subgroup heterogeneity was present only for N-acetylcysteine. No publication bias was discerned. LIMITATIONS: All trials evaluated the surrogate end point of contrast-induced nephropathy as the primary outcome. The lack of a statistically significant renoprotective effect of theophylline may result from insufficient data or study heterogeneity. True study quality remains uncertain. CONCLUSION: N-acetylcysteine is more renoprotective than hydration alone. Theophylline may also reduce risk for contrast-induced nephropathy, although the detected association was not significant. Our data support the administration of N-acetylcysteine prophylaxis, particularly in high-risk patients, given its low cost, availability, and few side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,379
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Hospital-acquired renal insufficiency: A prospective study
Hou, S. H., Bushinsky, D. A., Wish, J. B., Cohen, J. J., & Harrington, J. T. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90618-6 · Cited by 1,238
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
Aspelin, P., Aubry, P., Fransson, S.-G., Strasser, R., Willenbrock, R., & Berg, K. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021833 · Cited by 1,136
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Merten, G. J., Burgess, W. P., Gray, L. V., Holleman, J. H., Roush, T. S., Kowalchuk, G. J., Bersin, R. M., Van Moore, A., Simonton III, C. A., Rittase, R. A., et al. (2004) · JAMA · doi:10.1001/jama.291.19.2328 · Cited by 1,087
Cited by
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Moll, F. L., Powell, J. T., Fraedrich, G., Verzini, F., Haulon, S., Waltham, M., van Herwaarden, J. A., Holt, P. J. E., van Keulen, J. W., Rantner, B., et al. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.09.011 · Cited by 1,468
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., Susantitaphong, P., Rocco, M., Vanholder, R., Sever, M. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60126-x · Cited by 1,154
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury
Palevsky, P. M., Liu, K. D., Brophy, P. D., Chawla, L. S., Parikh, C. R., Thakar, C. V., Tolwani, A. J., Waikar, S. S., & Weisbord, S. D. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.349 · Cited by 935
Metadata
- Authors
- Kelly, A. M., Dwamena, B., Cronin, P., Bernstein, S. J., & Carlos, R. C.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2008-02-19
- Volume
- 148
- Issue
- 4
- Pages
- 284-294
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2009174838
- Cited by
- 435
- References
- 40
- FWCI
- 42.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy. https://app.cochat.ai/papers/10.7326/0003-4819-148-4-200802190-00007
- The paper
- Kelly, A. M., Dwamena, B., Cronin, P., Bernstein, S. J., & Carlos, R. C. (2008). Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-4-200802190-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.